Conditions: Diabetes Mellitus, Type 2
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 27
Healthy volunteers: no

Brief summary:
The aim of the study is to generate pharmacokinetic and pharmacodynamic data to identify the safe-effective dose of empagliflozin in children and adolescents aged 10 to less than 18 years with type 2 diabetes mellitus.

Detailed description:

Arms:
arm 1: Patient to receive a high dose of empagliflozin arm 2: Patient to receive a medium dose of empagliflozin arm 3: Patient to receive a low dose of empagliflozin

Interventions: intervention 1: empagliflozin medium dose intervention 2: empagliflozin high dose intervention 3: empagliflozin low dose
Intervention descriptions: intervention 1: None intervention 2: None intervention 3: None

Protocol document: